Center for Research in Agricultural Genomics (Bellaterra)

Global Genomics Market Research Report 2022

Retrieved on: 
Monday, January 23, 2023
Conditional sentence, Data analysis, DSM-IV codes, Gene, Health, 2021–2023 inflation surge, DNA, Virginia Department of Agriculture and Consumer Services, D, FDA, RNA, Growth, Application, Plant, Progress, Medicine, Center for Research in Agricultural Genomics (Bellaterra), Genome, R, Agriculture, Investment, System, Science, Synthetic biology, Video game, Antibiotics, Vaccine, Pharmaceutical industry, Personalization, Genomics

The global genomics market is anticipated to observe an impressive growth during the forecast period, 2023-2027

Key Points: 
  • The global genomics market is anticipated to observe an impressive growth during the forecast period, 2023-2027
    The major factors include growing specialized medicines and wide application of genomics in numerous areas.
  • Growing importance of specialized medicines is one of the primary factors, supporting the growth of genomics market.
  • Other factors, such as massive research and development (R&D) activities in the bioinformatics sector and the increasing demand for next-generation sequencing services, are anticipating the growth of the market.
  • United States is expected to be a lucrative market in the forecast period due to rising importance of personalized medicines and wide application of genomics in the country.

Global Genomics Market Research Report 2022: Industry Size, Share, Trends, Opportunity, and Forecasts, 2017-2022 & 2023-2027 - ResearchAndMarkets.com

Retrieved on: 
Thursday, January 19, 2023
Genetics, Pharmaceutical, Health, Genome, R, System, The Surge, DNA, Precision medicine, FDA, Virginia Department of Agriculture and Consumer Services, Agriculture, Conditional sentence, Gene, Progress, Growth, Application, RNA, Synthetic biology, Science, Data analysis, Center for Research in Agricultural Genomics (Bellaterra), Plant, Investment, D, Antibiotics, Vaccine, Pharmaceutical industry, Fine chemical, Genomics, Personalization

The global genomics market is anticipated to observe an impressive growth during the forecast period, 2023-2027

Key Points: 
  • The global genomics market is anticipated to observe an impressive growth during the forecast period, 2023-2027
    The major factors include growing specialized medicines and wide application of genomics in numerous areas.
  • Genomics is the branch of science that concerned with the structure, function, evolution, and mapping of genomes.
  • Various steps are taken such as sampling, sequencing, data analysis and interpretation procedures to decode, assemble, and analyze genomes.
  • Growing importance of specialized medicines is one of the primary factors, supporting the growth of genomics market.

Standard BioTools Releases the X9 Real-Time PCR System, Its Most Productive and Flexible High-Capacity Genomics Platform

Retrieved on: 
Thursday, October 6, 2022
SAN, LinkedIn, Trinidad and Tobago Securities and Exchange Commission, IFC, Disease, Center for Research in Agricultural Genomics (Bellaterra), SEC, Regulation Fair Disclosure, Government, Efficiency, Standard, Genomics, Annual report, Biotechnology, Microfluidics, Research, Twitter, Security (finance), PCR, Private Securities Litigation Reform Act, Solution, Company, Industry, Health, Doctor of Philosophy, Regulation, Immunotherapy, Social media, GLOBE, Forward-looking statement, Disclosure, Fine chemical, Medical device, Fluidigm, Facebook

The X9 System integrates proven Standard BioTools proprietary microfluidics technology, which helps reduce experimental costs while accommodating relevant and popular applications and chemistries to meet the most demanding customer needs.

Key Points: 
  • The X9 System integrates proven Standard BioTools proprietary microfluidics technology, which helps reduce experimental costs while accommodating relevant and popular applications and chemistries to meet the most demanding customer needs.
  • Standard BioTools, the Standard BioTools logo, Fluidigm, and Fluidigm logo, Unleashing tools to accelerate breakthroughs in human health, and X9 are trademarks and/or registered trademarks of Standard BioTools Inc. or its affiliates in the United States and/or other countries.
  • Such information may be deemed material information, and Standard BioTools may use these channels to comply with its disclosure obligations under Regulation FD.
  • Therefore, investors should monitor Standard BioTools website and its social media accounts in addition to following its press releases, SEC filings, public conference calls, and webcasts.